105 related articles for article (PubMed ID: 2025483)
21. Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs.
Keegan MT; Brown DR; Rabinstein AA
Anesth Analg; 2006 Dec; 103(6):1466-8. PubMed ID: 17122225
[TBL] [Abstract][Full Text] [Related]
22. Antipyrine elimination by patients under treatment with monoamine oxidase inhibitors.
Smith SE; Lambourn J; Tyrer PJ
Br J Clin Pharmacol; 1980 Jan; 9(1):21-5. PubMed ID: 7356888
[TBL] [Abstract][Full Text] [Related]
23. [Irreversible, non-selective monoamine oxidase inhibitors].
Castberg I; Spigset O
Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
[TBL] [Abstract][Full Text] [Related]
24. Topical cocaine nasal anesthesia.
Gordon BR
Arch Otolaryngol Head Neck Surg; 1987 Feb; 113(2):211. PubMed ID: 3801182
[No Abstract] [Full Text] [Related]
25. Phenelzine: acetylator status and clinical response.
Sanders GL; Rawlins MD
Br J Clin Pharmacol; 1979 May; 7(5):451-2. PubMed ID: 475942
[No Abstract] [Full Text] [Related]
26. Monoamine oxidase inhibitor-induced speech blockage.
Goldstein DM; Goldberg RL
J Clin Psychiatry; 1986 Dec; 47(12):604. PubMed ID: 3782047
[TBL] [Abstract][Full Text] [Related]
27. Bronchoscopy in adults under topical anesthesia.
Rayl JE
Surg Annu; 1973; 5():169-203. PubMed ID: 4602214
[No Abstract] [Full Text] [Related]
28. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
Nolen WA
Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
[TBL] [Abstract][Full Text] [Related]
29. Unusual reaction to monoamine oxidase inhibitor.
Gardner LD
Br Med J; 1979 May; 1(6172):1218-9. PubMed ID: 445031
[No Abstract] [Full Text] [Related]
30. Acute dystonic reaction induced by a monoamine oxidase inhibitor.
Jarecke CR; Reid PJ
J Clin Psychopharmacol; 1990 Apr; 10(2):144-5. PubMed ID: 2341590
[No Abstract] [Full Text] [Related]
31. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
[TBL] [Abstract][Full Text] [Related]
32. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
[TBL] [Abstract][Full Text] [Related]
33. Letter: Interactions with monoamine oxidase inhibitors.
McGilchrist JM
Br Med J; 1975 Sep; 3(5983):591-2. PubMed ID: 1174832
[No Abstract] [Full Text] [Related]
34. Phenelzine treatment of selective mutism in four prepubertal children.
Golwyn DH; Sevlie CP
J Child Adolesc Psychopharmacol; 1999; 9(2):109-13. PubMed ID: 10461821
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S
Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888
[TBL] [Abstract][Full Text] [Related]
36. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
Modai I; Beigel Y; Cygielman G
J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
Safferman AZ; Masiar SJ
Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
[TBL] [Abstract][Full Text] [Related]
39. [THE EFFECT OF A MONOAMINE OXIDASE INHIBITOR ON THE ELIMINATION OF BUFOTENIN AND ON THE SYMPTOMS OF CHRONIC NON-PRODUCTIVE SCHIZOPHRENIA].
FISCHER E; HELLER B
Ann Med Psychol (Paris); 1965 Apr; 123():614-22. PubMed ID: 14296667
[No Abstract] [Full Text] [Related]
40. A case report of leukopenia associated with phenelzine.
Tipermas A; Gilman HE; Russakoff LM
Am J Psychiatry; 1984 Jun; 141(6):806-7. PubMed ID: 6731626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
